PMID: 15228153Jul 2, 2004Paper

The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity

Therapeutic Drug Monitoring
Terrence J MonksSerrine S Lau


3,4-Methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are ring-substituted amphetamine derivatives with stimulant and hallucinogenic properties. The recreational use of these amphetamines, especially MDMA, is prevalent despite warnings of irreversible damage to the central nervous system. MDA and MDMA are primarily serotonergic neurotoxicants. Because (1) neither MDA nor MDMA produces neurotoxicity when injected directly into brain, (2) intracerebroventricular (i.c.v.) administration of some major metabolites of MDA and MDMA fails to reproduce their neurotoxicity, (3) alpha-methyldopamine (alpha-MeDA) and N-methyl-alpha-MeDA are metabolites of both MDA and MDMA, (4) alpha-MeDA and N-methyl-alpha-MeDA are readily oxidized to the corresponding ortho-quinones, which can undergo conjugation with glutathione (GSH), and (5) quinone thioethers exhibit a variety of toxicologic activities, we initiated studies on the potential role of thioether metabolites of alpha-MeDA and N-methyl-alpha-MeDA in the neurotoxicity of MDA and MDMA. Our studies have revealed that the thioether conjugates stimulate the acute release of serotonin, dopamine, and norepinephrine and produce a behavioral response commensurate...Continue Reading


Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·G Rudnick, S C Wall
Nov 1, 1992·Journal of Neurochemistry·B Halliwell
Oct 1, 1991·Journal of Clinical Psychopharmacology·Una D McCann, George A Ricaurte
Jun 1, 1990·The Journal of Clinical Investigation·R KannanN Kaplowitz
Dec 17, 1997·Experimental Neurology·T J MontineD G Graham
May 23, 1998·Annual Review of Pharmacology and Toxicology·Terrence J Monks, S S Lau
Jul 22, 1998·European Journal of Pharmacology·R R MetzgerA E Fleckenstein
Nov 17, 1998·Chemical Research in Toxicology·H E KleinerS S Lau
Dec 17, 1998·Neurology·K I BollaGeorge A Ricaurte
Apr 29, 1999·Journal of Neuroscience Research·A H StokesK E Vrana
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·J G Chen, G Rudnick
Mar 25, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthias E LiechtiF X Vollenweider


Jan 11, 2005·Neurotoxicity Research·H G Baumgarten, L Lachenmayer
Mar 7, 2012·Archives of Toxicology·Márcia CarvalhoMaria Lourdes Bastos
Nov 2, 2013·Archives of Toxicology·Daniel José BarbosaFélix Carvalho
Apr 18, 2009·Molecular Neurobiology·J P CapelaFélix Carvalho
Aug 24, 2010·Journal of the International Neuropsychological Society : JINS·Mariana ChernerHNRC Group
Aug 20, 2010·Journal of Agricultural and Food Chemistry·Joshua D LambertChung S Yang
May 12, 2011·Chemical Research in Toxicology·Anne NeudörfferMartine Largeron
Oct 19, 2006·Pharmacogenetics and Genomics·Helena CarmoJan G Hengstler
Apr 8, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ximena PerfettiRafael de la Torre
Jul 25, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Melanie MuellerGeorge A Ricaurte
Aug 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael H BaumannMarilyn A Huestis
Apr 5, 2011·Clinical Pharmacokinetics·Samanta Yubero-LahozRafael de la Torre
Dec 14, 2011·The Veterinary Quarterly·Irene Antolino-LoboMajorie B M van Duursen
Oct 14, 2008·Toxicology·Helena PontesMaria Lourdes Bastos
Jan 22, 2008·Free Radical Biology & Medicine·Joshua D LambertChung S Yang
May 1, 2007·Neuroscience·J P CapelaFélix Carvalho
Dec 29, 2006·Chemistry & Biodiversity·Daniel TrachselFranz Baumberger
Jun 20, 2007·Rapid Communications in Mass Spectrometry : RCM·Lekha SlenoGérard Hopfgartner
Mar 9, 2007·Biomedical Chromatography : BMC·Renata SilvaFernando Remião
Sep 24, 2004·Trends in Pharmacological Sciences·Rafael de la Torre, Magí Farré
Mar 21, 2009·Annales pharmaceutiques françaises·M-B FleuryMartine Largeron
Jun 6, 2006·Journal of Psychiatric Research·Katja SchlichtBrigitta Bondy
Apr 4, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Karl B Scheidweiler, Marilyn A Huestis
Sep 13, 2016·Chemical Research in Toxicology·Judy L Bolton, Tareisha Dunlap

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.